PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

NCT05007145 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

92

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Neoplasms
Esophageal Squamous Cell Carcinoma

Interventions

DRUG: PD-1 inhibitor
DRUG: Albumin-Bound Paclitaxel
DRUG: Cisplatin
RADIATION: Radiation

Sponsor

Fujian Cancer Hospital

Collaborators

[object Object]